Mimedx (MDXG) Change in Account Payables (2012 - 2026)
Mimedx's (MDXG) quarterly Change in Account Payables came in at $1.9 million in Q1 2026, up 32.6% year-on-year from $1.5 million in Q1 2025, and up 222.07% quarter-over-quarter from -$1.6 million in Q4 2025.
Mimedx (MDXG) Change in Account Payables (2012 - 2026) Analysis & Trends
Mimedx has disclosed Change in Account Payables across 15 years of filings, most recently posting $1.9 million for Q1 2026.
- Change in Account Payables for Q1 2026 came in at $1.9 million, up 32.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (up 1213.73% YoY), and the FY2025 annual result was $2.1 million, up 250.28% from the prior year.
- Change in Account Payables came in at $1.9 million for Q1 2026 at Mimedx, up from -$1.6 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.9 million in Q3 2025 to a low of -$1.6 million in Q4 2025.
- The 5-year median for Change in Account Payables is $283000.0 (2024), against an average of $251000.0.
- Across the five-year window, Change in Account Payables jumped 6878.57% in 2023 and slumped 330.68% in 2024, its largest moves.
- Mimedx's Change in Account Payables stood at -$251000.0 in 2022, then surged by 126.69% to $67000.0 in 2023, then jumped by 964.18% to $713000.0 in 2024, then slumped by 322.44% to -$1.6 million in 2025, then soared by 222.07% to $1.9 million in 2026.
- The last three Change in Account Payables figures came in at $1.9 million (Q1 2026), -$1.6 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | 1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.94 Mn |
| Mar 31, 2026 | 1.94 Mn |
| Dec 31, 2025 | -1.59 Mn |
| Dec 31, 2025 | -1.59 Mn |
| Sep 30, 2025 | 2.91 Mn |
| Sep 30, 2025 | 2.91 Mn |
| Jun 30, 2025 | -668,000.00 |
| Jun 30, 2025 | -668,000.00 |
| Mar 31, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 713,000.00 |
| Dec 31, 2024 | 713,000.00 |
| Sep 30, 2024 | -1.05 Mn |
| Sep 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -1.36 Mn |
| Jun 30, 2024 | -1.36 Mn |
| Mar 31, 2024 | 283,000.00 |
| Mar 31, 2024 | 283,000.00 |
| Dec 31, 2023 | 67,000.00 |
| Dec 31, 2023 | 67,000.00 |